Archive for April 2020

Dr Jo Dixon-Hardy is the Director of Medical Technologies Innovation. A year ago, I wrote about how the Medical Technologies IKC has used its experiences and the processes it has developed and tested over the past ten years to extend successful innovation practice across academic research translation programmes both regionally and nationally. At that point, we […]

Dr Jo Dixon-Hardy is the Director of Medical Technologies Innovation. Among the IKC’s most energising achievements has been its success in extending successful innovation practice across academic research translation programmes both regionally and nationally. Our distinctive contribution is driven by our technology innovation managers (TIMs). Because they all have extensive experience of developing commercial products in […]

Professor John Fisher is the Academic Director of the Medical Technologies IKC. Since our launch in 2009, the IKC has adapted its strategic approach to respond to external changes, but our core principles remain the same: bringing together different disciplines and different technologies to take research closer to commercialisation. By specifically focusing on the translation […]

In this interview with RegMedNet, Dr Hazel Fermor (Lecturer in Musculoskeletal Regenerative Medicine, University of Leeds) discusses the challenges and applications of decellularised tissue in cartilage repair. What interests you in this area? There is a huge patient demand for effective treatments; I’m sure all of us know someone who has got osteoarthritis. The ability […]

In this interview with RegMedNet, Dr Mike Raxworthy (Medical Technologies IKC, Regener8 and Neotherix) discusses the development of an electrospun scaffold for tissue regeneration. He also discusses the evolution of the regenerative medicine industry in the UK, and the IKC’s community – Regener8.    

Forging strong working partnerships with different types of organisations is fundamental to the IKC’s success. It supports our core aim of translating new medtech innovation and allows us to learn and share good practice. Our partnership with Arthritis Research UK on their medical technologies proof of concept programme is a great example. The IKC helps […]

Welcome to the first IKC-Regener8 newsletter of 2018. It is my pleasure to wish all Regener8 members and readers a very satisfying and successful New Year.

As activities begin to step-up again after the summer, we are as keen as ever to build the UK regenerative devices community with advice, expertise and support. The priorities of the Medical Technologies IKC remain as enabling the commercialisation of UK science base – particularly for the regenerative devices sector, supporting businesses to start and grow, and developing skills to help people and businesses thrive.

A collaborative approach to translational research is the foundation of a successful partnership between the IKC and Arthritis Research UK. This year, five new projects have been awarded Proof of Concept funding and project support.

MedTech BEST (Business and Entrepreneurial Skills Training) is about taking research into the marketplace (translation). Participants on the course learn about the skills, evidence, and regulations needed and the challenges likely to be encountered along this pathway. The task is to develop a MedTech product concept to solve a verified clinical need. The concept will […]